Subject Areas on Research
- Is This a 737 Max Moment for Brolucizumab?
- MERLIN: Phase 3a, Multicenter, Randomized, Double-Masked Trial of Brolucizumab in Participants with Neovascular Age-Related Macular Degeneration and Persistent Retinal Fluid.
- Retinal Vasculitis and Intraocular Inflammation after Intravitreal Injection of Brolucizumab.
- Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion-Related Events with Brolucizumab: Post Hoc Review of HAWK and HARRIER.
- The relationship between retinal vessel calibre and knee cartilage and BMLs.